A guide for PT practice owners preparing for a sale — what federal compliance gaps buyers find, why they care, and exactly how each one destroys your purchase price.
You've spent years building a profitable physical therapy practice. Now you're ready to sell. You've received a letter of intent with a valuation that exceeds your expectations. But before a single dollar changes hands, the buyer's due diligence team — often forensic accountants and healthcare compliance attorneys — will spend weeks auditing every claim you've ever submitted to Medicare and Medicaid. What they find in those records will determine whether your deal closes at the agreed price, at a dramatically reduced price, or not at all. This guide explains the seven most common federal compliance issues that derail PT acquisitions — and why sophisticated buyers treat them as existential deal risks.
In a healthcare acquisition, the buyer doesn't just purchase your assets and patient list — they inherit your history. Under federal law, if a buyer acquires a practice with a history of improper Medicare billing, the new owner is fully liable for those historical overpayments and potential penalties. The government doesn't care that the new owner wasn't in charge when violations occurred. Because of this, buyers treat any compliance gap as a massive, unquantifiable financial threat.
Deals rarely die in shouting matches — they die in the Quality of Earnings (QoE) spreadsheet. PT practices are valued on a multiple of EBITDA. If a buyer agrees to a 5× multiple and discovers 15% of revenue came from non-compliant billing, they won't just subtract 15% from the price. They strip the revenue, add compliance overhead costs, and multiply the newly reduced profit by 5×. An $8 million offer can collapse to $3 million — and the seller walks.
For issues like the Stark Law (physician self-referrals), the government operates on strict liability — intent is irrelevant. It doesn't matter if the seller didn't know their lease with a referring physician was structured illegally. If the financial relationship violates Stark Law, every Medicare claim tied to that referral source is considered tainted and subject to recoupment. Buyers will not inherit a strict liability risk under any circumstances.
Private equity and strategic buyers are hyper-paranoid about PT billing because federal regulators are. The HHS Office of Inspector General (OIG) actively targets outpatient physical therapy in its annual work plans. Buyers know this sector is under intense federal scrutiny, so their due diligence is intentionally ruthless to protect their investment.
A review of provider schedules and billing logs reveals therapists regularly billing for more one-on-one time than physically exists in a workday — for example, billing 12 hours of direct therapeutic CPT codes in an 8-hour shift. This "impossible day" pattern is often the result of double-booking Medicare patients while billing time-based codes as if each session was conducted individually and sequentially.
Medicare strictly mandates the 8-Minute Rule for time-based codes such as therapeutic exercise, manual therapy, and neuromuscular re-education. To bill a single billable unit, the therapist must provide continuous, direct, one-on-one skilled service for at least 8 minutes. Double-booking two Medicare patients simultaneously and billing separate time-based codes for both constitutes fraudulent upcoding with significant civil and criminal exposure.
Why It Kills the Deal: Buyers will extrapolate the overbilling error rate across the entire Medicare patient base. If 30% of the practice's revenue is tied to non-compliant time-based billing, the actual valuation collapses proportionally — and the risk of a Medicare audit forcing catastrophic clawbacks makes the asset too toxic to acquire at any price.
The Compliant Alternative — CPT 97150: If a therapist is treating two Medicare patients simultaneously, they are not prohibited from doing so — but they cannot bill one-on-one time-based codes for either patient. The correct code is CPT 97150 (Therapeutic Exercises, Group), which applies when a therapist treats two or more patients at the same time. Forensic accountants specifically look for the absence of CPT 97150 in heavily double-booked schedules — because a practice treating patients in groups but billing individual time-based codes has no legitimate explanation for the discrepancy.
The practice's profit margins appear exceptional because operations rely heavily on unlicensed rehab aides, technicians, or students to perform the bulk of patient treatments — while the licensed PT handles evaluations and administrative tasks. The billing, however, presents these services as if they were performed by a licensed provider. A specific red flag: students treating patients independently in a separate room while the supervising PT is simultaneously treating another patient elsewhere in the clinic.
Under Medicare rules, services performed by physical therapy aides or technicians are never covered, even if performed under the direct, line-of-sight supervision of a licensed Physical Therapist. Only services provided by a PT — or by a properly supervised Physical Therapist Assistant (PTA) under specific supervision protocols — are billable to Medicare. Students occupy a narrow middle ground: Medicare Part B does permit billing for services involving a student, but the licensed PT must be physically present in the same room for the entire session, actively directing the service and taking full clinical responsibility — while not simultaneously treating any other patient. The moment the PT steps out or treats another patient concurrently, the student session becomes non-billable.
Why It Kills the Deal: A buyer will immediately discount all revenue generated by unlicensed staff. For student-supervised sessions specifically, buyers will pull daily notes looking for explicit "in the room" supervision documentation — and its absence is treated as fraudulent billing. More broadly, if the practice's operational model relies on cheap labor to maintain margins, the buyer knows they must completely restructure the staffing model post-close to achieve compliance. This destroys projected profitability, often making the business entirely unviable at the agreed purchase price.
Billing data shows an unusually high frequency of Modifier 59 or the KX Modifier attached to claims — particularly when these modifiers appear to be applied automatically by billing software rather than through individual clinical review. A related red flag: the complete absence of the more specific X{EPSU} modifiers (XE, XS, XP, XU), which CMS introduced specifically to replace the broad, catch-all use of Modifier 59. High Modifier 59 rates combined with zero X modifier usage signals outdated, lazy coding practices to any sophisticated buyer audit team.
Modifier 59 indicates a "distinct procedural service," allowing providers to bypass NCCI edits that would otherwise bundle services together. The KX Modifier attests that treatment beyond Medicare's targeted therapy threshold is medically necessary. Both require individualized claim-by-claim documentation. Critically, CMS created the X{EPSU} modifiers — XE (separate encounter), XS (separate structure/body part), XP (separate practitioner), XU (unusual non-overlapping service) — to replace Modifier 59's overly broad use. Modern, compliant billing uses these granular modifiers; a practice still blanketing claims with Modifier 59 alone has not kept pace with CMS guidance and is a prime NCCI audit target.
Why It Kills the Deal: If a buyer's audit team pulls charts with KX modifiers and finds no clinical documentation justifying extended skilled therapy, they must assume all KX-modified claims are overpayments. On the Modifier 59 side, sophisticated buyers now specifically check whether a practice has adopted the X{EPSU} modifiers. A practice that hasn't is signaling to the buyer that its billing department isn't current with CMS guidance — a red flag that invites deeper scrutiny of every claim in the portfolio and raises the likelihood of an active NCCI edit audit.
Daily treatment notes appear identical visit after visit — a telltale sign of copy-paste or "cloning" — failing to document patient progress, functional changes, or the clinical reasoning behind treatment modifications. Simultaneously, patient charts consistently lack a signed Plan of Care (POC) from the referring physician, or the POC was signed outside of required timeframes.
Medicare requires a Plan of Care to be certified — signed and dated — by a physician or qualified non-physician practitioner. Furthermore, every daily note must explicitly document that the interventions required the skills of a licensed therapist. The Medicare standard is clear: "if it wasn't documented, it wasn't done." Cloned notes fail to demonstrate medical necessity or skilled care.
Recertifications must be physically signed and dated by the physician every 90 days or upon any significant change in the plan. There is no exception for recertifications — a missed signature is an automatic denial.
Effective January 1, 2025, CMS finalized an exception to the physician signature requirement for the initial Plan of Care. This is real — but sellers who interpret it as "buyers don't care anymore" are making a costly mistake. Buyer audit teams view this rule with more scrutiny, not less.
To legally bypass the physician signature on the initial POC, both conditions must be met perfectly:
When a buyer's Quality of Earnings team reviews a clinic relying on the 2025 transmission exception, they demand hard evidence for every chart:
Bottom line: the 2025 rule shifted the paperwork burden — it did not eliminate the compliance requirement. Buyers verify the system, not just the intent.
Why It Kills the Deal: If a buyer's clinical audit reveals that 40% of Medicare charts lack valid, defensible POC documentation — whether due to missing signatures, failed transmission proof, or unsigned recertifications — they will strip that revenue from the valuation. As shown above, this calculation compounded by the EBITDA multiple routinely drops purchase prices below what sellers are willing to accept, causing deals to collapse entirely.
The practice has questionable financial relationships with referral sources. Common examples include: paying a referring orthopedic surgeon an inflated fee to serve as a nominal "Medical Director," renting office space from a referring physician group at above or below fair market value, or structuring the seller's post-close earn-out compensation based on their future referral volume to the clinic after the sale closes.
The Anti-Kickback Statute (AKS) is a federal criminal law prohibiting the exchange of anything of value — directly or indirectly — to induce or reward referrals for federal healthcare program patients. The Stark Law is a strict-liability civil statute prohibiting physician self-referral to entities with which they have a financial relationship. Under Stark, intent is irrelevant — the structure of the relationship is all that matters.
Why It Kills the Deal: This is the most dangerous red flag of all seven. Buyers will not acquire a practice whose patient pipeline is built on illegal kickbacks or self-referrals. The penalties for AKS violations include massive federal fines, exclusion from all federal healthcare programs, and prison time. Critically, if the deal itself is structured improperly — for example, tying the seller's post-close payments to how many Medicare patients they refer back — the acquirer steps directly into an ongoing federal crime at the moment of closing.
Safe Harbors — Not All Physician Relationships Are Illegal: Sellers preparing for market should understand that both the AKS and Stark Law include defined "Safe Harbors" and exceptions that legalize certain referral-source relationships when structured correctly. For example, renting clinic space from an orthopedic group is fully permissible under the Space Rental Safe Harbor — provided the arrangement is set in writing, established for a term of at least one year, and priced at strictly documented Fair Market Value (FMV) regardless of the volume or value of referrals generated. The key term is "documented." Buyers will demand independent FMV appraisals, signed lease agreements, and proof that rent was paid as agreed. A handshake arrangement — even one with benign intent — falls outside the Safe Harbor and taints every claim that flowed from that referral relationship. Actionable step: Before going to market, have every physician financial relationship reviewed by a healthcare attorney to confirm it meets a Safe Harbor, and secure an independent FMV analysis for any space, equipment, or services arrangement with a referral source.
During financial due diligence, the buyer's accountants compare the practice's billing system to their bank deposits. They notice that while Medicare is paying its 80% share of the claims, the clinic is rarely, if ever, collecting the remaining 20% patient copay/coinsurance.
Practice owners often waive copays as a "professional courtesy" to keep patient volume high or prevent patients from self-discharging early. However, under the Anti-Kickback Statute and the Civil Monetary Penalties Law, routinely waiving Medicare patient responsibility is considered offering illegal remuneration — a kickback — to induce the patient to receive federally funded services. Waivers are only legal if there is a documented, individualized assessment of financial hardship.
Why It Kills the Deal: Buyers view this as a double-barreled threat. First, every claim where a copay was routinely waived is tainted by a kickback, making the entire Medicare payment subject to recoupment. Second, if the clinic suddenly starts legally collecting copays after the acquisition, patient volume will inevitably drop — meaning the seller's historical revenue numbers are artificially inflated and cannot be replicated post-close.
Sellers often place patients on RTM platforms (CPT 98975, 98977, etc.) and set billing on "auto-pilot" without ensuring the clinical monitoring actually occurred. When buyers request software audit logs, the timestamps and data collection records frequently fail to match the billing ledger — exposing the revenue stream as unsupported and potentially fraudulent.
RTM billing requires strict adherence to data collection minimums — for example, 16 days of data per 30-day period — and documented interactive communication between the clinician and patient. CMS requires that the clinical monitoring actually occur and be verifiable in software logs. Billing for RTM services that were never delivered or cannot be documented constitutes a false claim under the False Claims Act.
Why It Kills the Deal: Buyers will strip RTM revenue out of EBITDA entirely if the software audit logs do not align precisely with the billing ledger. Because RTM codes can represent a significant and growing revenue line, this can dramatically compress the valuation multiple applied to the practice — or cause the buyer to walk away from the deal altogether.
Billing more direct treatment time than physically exists — often from double-booking Medicare patients for time-based codes.
Aides and techs are never billable. Students require the PT to be physically in the room, not treating anyone else — and buyers look for that documentation specifically.
Blanket use of Modifier 59 instead of the granular X{EPSU} modifiers, plus KX claims lacking clinical justification — both are prime NCCI audit triggers.
Copy-paste documentation that fails to show skilled care, plus missing or late physician Plan of Care certifications.
The most dangerous issue — carries criminal exposure. Legitimate physician relationships require documented Safe Harbor compliance and independent Fair Market Value appraisals.
Systematically forgiving Medicare copays without documented financial hardship assessments constitutes an illegal kickback — and inflates revenue figures that buyers cannot replicate post-close.
RTM codes require 16+ days of verified data per billing period. Buyers forensically audit software logs against the billing ledger — mismatches result in full revenue strip-out from EBITDA.
Every dollar of non-compliant revenue is stripped from EBITDA and then multiplied by the deal multiple — turning small percentages into millions of dollars of lost value.
Sellers who identify and remediate compliance issues before engaging buyers retain their leverage, their valuation, and their ability to walk away from unfavorable terms. Sellers who discover these issues mid-due diligence are at the mercy of a buyer who now holds all the cards. Mihama works with PT practice owners — often 12 to 24 months before a planned sale — to identify compliance vulnerabilities, help you engage the right legal and billing experts to remediate them, and position your practice to withstand the most aggressive buyer due diligence review.
347-878-2941
Confidential consultation, no retainer required
[email protected]
We respond within one business day
www.mihamainc.com
Resources, case studies & transaction experience